Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Cianfarano

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neuron|November 23, 2024
Identifying representational structure in CA1 to benchmark theoretical models of cognitive mappingJ Quinn Lee, Alexandra T Keinath, Erica Cianfarano, et al.
Cell Reports|January 30, 2026
Norepinephrine acts through radial astrocytes in the developing optic tectum to enhance threat detection and escape behaviorNicholas J Benfey, Finnley Cookson, David Foubert, et al.
Eneuro|January 12, 2026
RetINaBox: A Hands-On Learning Tool for Experimental NeuroscienceBrune Bettler, Flavia Arias Armas, Erica Cianfarano, et al.
Nature Communications|January 3, 2026
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trialApril A N Rose, Jennifer Maxwell, Emmanuelle Rousselle, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neuron|November 23, 2024
Identifying representational structure in CA1 to benchmark theoretical models of cognitive mappingJ Quinn Lee, Alexandra T Keinath, Erica Cianfarano, et al.
Cell Reports|January 30, 2026
Norepinephrine acts through radial astrocytes in the developing optic tectum to enhance threat detection and escape behaviorNicholas J Benfey, Finnley Cookson, David Foubert, et al.
Eneuro|January 12, 2026
RetINaBox: A Hands-On Learning Tool for Experimental NeuroscienceBrune Bettler, Flavia Arias Armas, Erica Cianfarano, et al.
Nature Communications|January 3, 2026
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trialApril A N Rose, Jennifer Maxwell, Emmanuelle Rousselle, et al.
Pageof 1